Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$1.7M in Q3 2026 · −$36.6M over twelve months
Operating cash flow$22.0M
Capital spending−$20.2M
Free cash flow+$1.7M
Cash / net income4.2×
Cash conversion cycle-29 days
Analysis
In Q3 2026, Aemetis generated $22.0M of operating cash flow and spent $20.2M on capital projects, leaving free cash flow of $1.7M. That is $2.8M more than in Q3 2025 (−$1.0M).
Over the twelve months to Sep 30, 2026, operating cash flow was $15.3M; the largest uses were capital spending ($51.9M), other financing ($39.6M); besides operations, cash came from net borrowing (+) / repaid (−) ($53.0M), shares issued ($18.1M); the cash balance fell by $3.7M.
Operating cash flow was $22.0M against net income of $5.2M — 4.2× profit, cash ran ahead of reported earnings. The largest differences: other liabilities −$4.7M, depreciation & amortization +$2.6M, receivables −$2.1M.
Its cash conversion cycle was -29 days (receivables 3 + inventory 21 − payables 53): suppliers fund its working capital.
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $22.0M, Capital spending $20.2M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled −$59.4M; the largest uses were capital spending ($145M) and operating cash flow ($76.4M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$3.4M
Debt$435M
Net debt$432M
Due within a year$377M
Aemetis's operations bring cash in ($15.3M over twelve months), and it spends more than that on capital projects: a gap of $36.6M funded from its $3.4M of cash and investments and from borrowing ($435M of debt, $377M due within a year). That is a choice to invest, not a cash runway running down.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
3
21
53
-29
Q2 2026
6
22
51
-22
Q1 2026
6
19
41
-16
Q4 2025
2
16
53
-35
Q3 2025
3
13
40
-24
Q2 2025
3
29
44
-12
Q1 2025
3
45
61
-13
Every quarter
Quarter
Operating cash flow
Capital spending
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$22.0M
−$20.2M
$16.0M
$1.8M
−$1.4M
$1.7M
Q2 2026
−$1.9M
−$8.5M
—
$7.2M
$3.3M
−$10.4M
Q1 2026
−$10.6M
−$6.5M
$16.0M
$6.6M
$1.0M
−$17.1M
Q4 2025
$5.8M
−$16.6M
$15.7M
$2.6M
$666K
−$10.8M
Q3 2025
$3.1M
−$4.1M
$7.9M
$7.5M
−$4.0M
−$1.0M
Q2 2025
−$5.7M
−$3.5M
$17.4M
$13.1M
−$1.2M
−$9.3M
Q1 2025
$160K
−$1.8M
$3.8M
$5.1M
$407K
−$1.7M
Q4 2024
−$12.6M
−$6.8M
$6.9M
$10.1M
−$538K
−$19.4M
Aemetis: income statement and cash flow
Aemetis, Q3 2026: revenue $88.2M (+49% year over year), operating margin 23.7%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.